How Cochlear™ Hybrid™ Hearing works
CochlearTM HybridTM Hearing solutions combine hearing aid and cochlear implant technologies. Learn how they work together.
What you'll find on this page
- The two parts of a Hybrid Hearing implant.
- How they work to produce sound.
How does Hybrid™ Hearing work?
The Cochlear™ Hybrid™ hearing solution has two parts: an external sound processor with an acoustic component and an internal implant.
The cochlear implant is designed to help you hear the high frequency sounds you have been missing, while the acoustic component amplifies the natural low-frequency hearing you have.
By working together, the components can provide a balanced hearing experience.
“Having the cochlear implant just means I get to have a lot more fun. I can communicate again and I can just enjoy the conversation that takes place.”
- Sandy B, Cochlear Hybrid Hearing recipient
Can a hybrid cochlear implant help you?
A hearing specialist can advise if a hybrid implant can help you.
A good next step is to visit a hearing health professional who specialises in hearing implant technology. They will know if you could benefit from a hybrid cochlear implant.
Find a hearing specialist near you
More information
Disclaimer
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
For a full list of Cochlear’s trademarks, please visit our Terms of Use page.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.